… Dr ClauwThere will always be individuals who fake or magnify symptoms to benefit financially,
but this is seen in a minority of patients. More problematic is the nonvolitional worsening …

Nociplastic pain is the semantic term suggested by the international community of pain
researchers to describe a third category of pain that is mechanistically distinct from nociceptive …

Fibromyalgia is the current term for chronic widespread musculoskeletal pain for which no
alternative cause can be identified. The underlying mechanisms, in both human and animal …

… Clauw has received consultant fees, speaking fees, and/or honoraria (less than $10,000
each) from Pfizer, Lilly, Forest, Cypress Biosciences, Pierre Fabre, UCB, and AstraZeneca. Dr. …

… Clauw MD c , Mary-Ann Fitzcharles MD d , Don L. Goldenberg MD e f , Winfried Häuser
MD g h , Robert L. Katz MD i , Philip J. … Ringold, D. Khanna, T. Neogi, SR Johnson, A. …

Objective. To develop a fibromyalgia (FM) survey questionnaire for epidemiologic and clinical
studies using a modification of the 2010 American College of Rheumatology Preliminary …

… Data from the 2 groups were compared by first reducing the results of each scan in each
person from a 3-dimensional (3-D) statistical volume to a 3-D volume of mean difference in …

Pain catastrophizing, or characterizations of pain as awful, horrible and unbearable, is
increasingly being recognized as an important factor in the experience of pain. The purpose of …

Objective For many individuals with chronic low back pain (CLBP), there is no identifiable
cause. In other idiopathic chronic pain conditions, sensory testing and functional magnetic …

… to other cohorts of fibromyalgia patients and may be compared with a mean ± SD score of
8.1 ± 2.1 found in 114 consecutive female patients from a general medicine clinic (D. Clauw, …